Literature DB >> 7792568

Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985.

J Angst1, M Preisig.   

Abstract

This paper reports the results of a 27 year prospective study of 186 unipolar depressives and 220 bipolar disorders meeting DSM-III criteria for major depression or mania. Subjects were classified into four diagnostic subgroups, according to polarity and presence or absence of schizophrenic symptoms: unipolar depression, bipolar disorder, unipolar schizoaffective disorder and bipolar schizoaffective disorder. Course parameters were assessed for all samples. As the sequence of subtypes of affective and schizoaffective disorders progresses from unipolar depression, schizodepression, pure affective bipolar disorder to schizobipolar disorder, a systematic decrease in age of onset and length of episode can be observed. When compared to unipolar disorders (unipolar depression and schizodepressive disorder), bipolar (bipolar and schizobipolar) disorders showed more periodicity, characterized by greater number of total episodes, more episodes per year, but with shorter episodes and cycles. Despite the lower age of onset among schizoaffective subjects compared to pure affective disorders, the only difference in course between the two groups was a greater frequency in episodes requiring hospitalization among schizoaffectives.

Entities:  

Mesh:

Year:  1995        PMID: 7792568

Source DB:  PubMed          Journal:  Schweiz Arch Neurol Psychiatr (1985)        ISSN: 0258-7661


  21 in total

1.  Enhancing medication adherence: in older adults with bipolar disorder.

Authors:  Colin A Depp; Barry D Lebowitz
Journal:  Psychiatry (Edgmont)       Date:  2007-06

2.  Ten-year diagnostic consistency of bipolar disorder in a first-admission sample.

Authors:  Camilo J Ruggero; Gabrielle A Carlson; Roman Kotov; Evelyn J Bromet
Journal:  Bipolar Disord       Date:  2010-02       Impact factor: 6.744

3.  Suicide and suicide attempts in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Authors:  Ellen B Dennehy; Lauren B Marangell; Michael H Allen; Cheryl Chessick; Stephen R Wisniewski; Michael E Thase
Journal:  J Affect Disord       Date:  2011-05-20       Impact factor: 4.839

Review 4.  A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force.

Authors:  Martha Sajatovic; Sergio A Strejilevich; Ariel G Gildengers; Annemiek Dols; Rayan K Al Jurdi; Brent P Forester; Lars Vedel Kessing; John Beyer; Facundo Manes; Soham Rej; Adriane R Rosa; Sigfried Ntm Schouws; Shang-Ying Tsai; Robert C Young; Kenneth I Shulman
Journal:  Bipolar Disord       Date:  2015-09-19       Impact factor: 6.744

5.  The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression.

Authors:  Esra Küçükibrahimoğlu; Melek Z Saygin; Mecit Calişkan; Okan K Kaplan; Cüneyt Unsal; M Zafer Gören
Journal:  Eur J Clin Pharmacol       Date:  2009-04-17       Impact factor: 2.953

6.  Mortality of 403 patients with mood disorders 48 to 52 years after their psychiatric hospitalisation.

Authors:  Jules Angst; Michael P Hengartner; Alex Gamma; Detlev von Zerssen; Felix Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-11-04       Impact factor: 5.270

7.  Questioning kindling: An analysis of cycle acceleration in unipolar depression.

Authors:  Samantha F Anderson; Scott M Monroe; Paul Rohde; Peter M Lewinsohn
Journal:  Clin Psychol Sci       Date:  2015-07-24

8.  The impact of classification on psychopharmacology and biological psychiatry.

Authors:  H M van Praag
Journal:  Dialogues Clin Neurosci       Date:  1999-12       Impact factor: 5.986

9.  Predictors of time to relapse/recurrence after electroconvulsive therapy in patients with major depressive disorder: a population-based cohort study.

Authors:  Axel Nordenskjöld; Lars von Knorring; Ingemar Engström
Journal:  Depress Res Treat       Date:  2011-11-03

10.  Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.

Authors:  G M Goodwin; P M Haddad; I N Ferrier; J K Aronson; Trh Barnes; A Cipriani; D R Coghill; S Fazel; J R Geddes; H Grunze; E A Holmes; O Howes; S Hudson; N Hunt; I Jones; I C Macmillan; H McAllister-Williams; D R Miklowitz; R Morriss; M Munafò; C Paton; B J Saharkian; Kea Saunders; Jma Sinclair; D Taylor; E Vieta; A H Young
Journal:  J Psychopharmacol       Date:  2016-03-15       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.